High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification

机译：高通量血液透析通过降低血清FGF-23水平和减少血管钙化而使血液透析患者受益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundHigh- and low-flux hemodialysis (HFHD and LFHD, respectively) are dialysis procedures designed to eliminate blood toxins that accumulate in end-stage renal disease. HFHD may reduce vascular calcification by removing serum fibroblast growth factor 23 (FGF-23). However, whether HFHD is better than LFHD is still under debate. We therefore compared the efficacy of HFHD and LFHD in controlling FGF-23 and vascular calcification.

机译：背景高通量和低通量血液透析（分别为HFHD和LFHD）是旨在消除终末期肾脏疾病中积聚的血液毒素的透析程序。 HFHD可通过去除血清成纤维细胞生长因子23（FGF-23）来减少血管钙化。但是，HFHD是否优于LFHD仍存在争议。因此，我们比较了HFHD和LFHD在控制FGF-23和血管钙化中的功效。

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Xiao Fu; Qin-Qin Cui; Jian-Ping Ning; Shuang-Shuang Fu; Xiao-Hua Liao;
展开▼
作者单位

展开▼
年(卷),期 2015(21),-1
年度 2015
页码 3467–3473
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Fibroblast Growth Factors Hemodialysis Solutions Renal Insufficiency Chronic Vascular Calcification;

机译：成纤维细胞生长因子;血液透析溶液;肾功能不全;慢性;血管钙化;

相似文献

外文文献
中文文献
专利

1. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification [J] . Xiao Fu, Qin-Qin Cui, Jian-Ping Ning, Medical science monitor : . 2015,第1期

机译：高通量血液透析通过降低血清FGF-23水平和减少血管钙化而使血液透析患者受益
2. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients [J] . Turan Mehmet Nuri, Kircelli Fatih, Yaprak Mustafa, International Urology and Nephrology . 2016,第4期

机译：血液透析患者中FGF-23水平与血管钙化有关，但与动脉粥样硬化无关
3. Study on the relationship between serum 25-hydroxyvitamin D levels and vascular calcification in hemodialysis patients with consideration of seasonal variation in vitamin D levels [J] . ChangJ.H., RoH., KimS., Atherosclerosis . 2012,第2期

机译：考虑维生素D水平季节性变化的血液透析患者血清25-羟维生素D水平与血管钙化关系的研究
4. Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels [C] . Masaki Ohya, Mitsuru Yashiro, Tomohiro Sonou, Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai . 2018

机译：静脉内的Maxacalcitol治疗与血液透析患者的血清成纤维细胞生长因子23水平与血清磷酸盐或钙水平无关相关
5. FACTORS AFFECTING SERUM LIPID LEVELS IN RENAL PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS TREATMENTS (DISEASE, DIET THERAPY). [D] . SALTOS, ETTA ANGEL. 1985

机译：正在进行维持性血液透析或连续性非循环性腹膜透析治疗（疾病，饮食疗法）的肾病患者血清脂水平的影响因素。
6. Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients [O] . H. Eskandari Naji, A. Ghorbanihaghjo, H. Argani, 2017

机译：血液透析和肾移植患者的血清sTWEAK和FGF-23水平
7. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification [O] . Xiao Fu, Qin-Qin Cui, Jian-Ping Ning, 2015

机译：通过减少血清FGF-23水平并减少血管钙化，高通量血液透析患者益于血液透析患者

High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification

摘要

著录项

相似文献

相关主题

期刊订阅